相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors
Victor Cervera-Carrascon et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Akintunde Akinleye et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model
Lukasz Kuryk et al.
ONCOIMMUNOLOGY (2019)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy
Joao Manuel Santos et al.
MOLECULAR THERAPY (2018)
TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
V. Cervera-Carrascon et al.
ONCOIMMUNOLOGY (2018)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy (vol 170, 1109.e1, 2017)
Antoni Ribas et al.
CELL (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses
Keisuke Watanabe et al.
JCI INSIGHT (2018)
Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy
Joao Manuel Santos et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
Silvia Pesce et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy
Riikka Havunen et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102-Support for clinical studies on advanced cancer treatment
Lukasz Kuryk et al.
PLOS ONE (2017)
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Emma Eriksson et al.
CLINICAL CANCER RESEARCH (2017)
A century of oncolysis evolves into oncolytic immunotherapy
O. Hemminki et al.
ONCOIMMUNOLOGY (2016)
Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress antitumor immune responses
Yu Zhang et al.
INTERNATIONAL IMMUNOLOGY (2016)
The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy
Jing-Zhang Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers
Tuuli Ranki et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues
Anniina Koski et al.
MOLECULAR THERAPY (2015)
Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
Alba Rodriguez-Garcia et al.
CLINICAL CANCER RESEARCH (2015)
PD-1 is a novel regulator of human B-cell activation
Marie-Laure Thibult et al.
INTERNATIONAL IMMUNOLOGY (2013)
Biodistribution and Safety Assessment of Bladder Cancer Specific Recombinant Oncolytic Adenovirus in Subcutaneous Xenografts Tumor Model in Nude Mice
Fang Wang et al.
CURRENT GENE THERAPY (2012)
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
Hongjie Wang et al.
NATURE MEDICINE (2011)
Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
Vincenzo Cerullo et al.
CANCER RESEARCH (2010)
A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
John Nemunaitis et al.
MOLECULAR THERAPY (2010)
INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies
B. Ying et al.
CANCER GENE THERAPY (2009)
Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors
MA Thomas et al.
CANCER RESEARCH (2006)
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus
A Kanerva et al.
MOLECULAR THERAPY (2003)
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses
A Kanerva et al.
MOLECULAR THERAPY (2002)
分享论文
